HOME >> MEDICINE >> NEWS
Geodon effective in psychiatric emergencies; Sharply reduces time in restraints

STONY BROOK, NY, March 30, 2005 ---- A study conducted under real-world, Emergency Department conditions by researchers at Stony Brook University Hospital has found that the injectable form of the second generation antipsychotic Geodon (ziprasidone) effectively calms the most severely agitated patients. The results, published in the current issue of General Hospital Psychiatry, also suggest that it may be possible to reduce by as much as 40 percent the time severely agitated patients spend in restraints during psychiatric emergencies. Additionally, the researchers at Stony Brook University Hospital found that medication was as effective in treating the severe agitation associated with alcohol and drug use as it was in treating non-substance or alcohol abusing patients.

This observational study tracked the clinical outcome of 110 severely agitated patients who received Geodon IM (intramuscular formulation). Initial agitation levels were high, ranging from 6.5 to 6.9 on a scale that ranges from a high of 7.0 to a low of zero. Within 30 minutes, whether the patients were psychotic, or had abused alcohol or drugs, their agitation scores dropped to a normal range. In addition to quickly relieving agitation, the results of the new study showed a reduction in physical restraints. The time period severely agitated patients treated with Geodon IM were held in restraints dropped by 40 percent compared to the period prior to this study when similar agitated patients received conventional antipsychotics--primarily haloperidol, known by the brand name Haldol. For more than 50 years, Haldol IM has been considered the gold standard of injectable antipsychotics, but its side effect profile offers disadvantages for patients. Approved in 2002, Geodon IM is the first second generation antipsychotic approved for the rapid control of acute agitation in patients.

"Being held in physical restraint is not only unpleasant, it also can be unsafe," said Andrew Franc
'"/>


30-Mar-2005


Page: 1 2

Related medicine news :

1. Strategy effective against drug resistant tuberculosis
2. Study shows patch therapy may be as effective as oral medications
3. Chronic pain treatments more effective when taken together, new study shows
4. Costs of antidepressants could have funded effective alternatives
5. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
6. Government wasting your taxpayer money on ineffective drug cure
7. Neurobehavioral function during coma, stroke rehabilitation effective for elderly
8. European folic acid policies are not effective enough
9. How effective are herbal supplements in reducing illnesses in children?
10. Cognitive behavioral therapy and medication is effective in the treatment of panic disorder
11. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis

Post Your Comments:
(Date:5/19/2013)... News) -- Although spring arrived late this year in ... will still be strong, according to a sinus expert ... Richard Waguespack, clinical professor in the university,s division of ... robust summer allergy season. However, some simple strategies can ... coughing, he added. "Tree pollen has been bad ...
(Date:5/19/2013)... According to a May 14th, 2013 Harper’s Bazaar ... about the appearance of certain areas of the body. ... fail to tone and tighten these areas. The report details ... get the firmest body possible (article: goo.gl/tPiha). , ... Simon Ourian, Medical Director of Epione Beverly Hills. “I don’t ...
(Date:5/19/2013)... People in Minnesota have a great option to get ... 28 Day Fat Loss Formula. The best part is ... own home. The product sells for $135 dollars and is ... here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is almost here. ... after using the 28 Day Fat Loss Formula they will ...
(Date:5/19/2013)... Idaho (PRWEB) May 19, 2013 The ... nerves for their functionality and one of the biggest ... the peripheral nervous system. The peripheral system comprises of ... the spinal cord. These nerves ensure that the limbs ... appropriately. However, when these nerves get damaged due to ...
(Date:5/19/2013)... 19, 2013 According to a ... and Forecast (2013 – 2018): By Applications (Healthcare ... Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) And ... sensor market was $8.00 billion in 2012 and ... at an estimated CAGR of 3.84% from 2013 ...
Breaking Medicine News(10 mins):Health News:Managing Seasonal Allergies 2Health News:Body Firming – The Hottest Treatments Available 2Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3
(Date:5/17/2013)... LUXEMBOURG , May 17, 2013  ConvaTec today announced that it ... Ken Berger , CEO, and Ed Borkowski ... AM ET live via telephone. To participate in the ... (877) 366-0267. To participate in the conference call outside the ... The conference ID is 72195398. Participants should dial in ...
(Date:5/17/2013)... May 17, 2013  PENTAX Medical, a healthcare ... a global leader in ultrasound imaging, recently announced ... to enable further innovation in the development of ... ultrasound systems and PENTAX Medical endoscopic portfolio have ... of EUS systems. This agreement will continue to ...
(Date:5/17/2013)... NATICK, Mass. , May 17, 2013  Boston ... to participate at the annual EuroPCR Scientific Program May ... "We are pleased to present a particularly rich and ... Keith Dawkins , M.D., global chief ... several trials will be presented, including the NG PROMUS ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
Cached News: